HK Stock Market Move | Zhuzhou CRRC Times Electric(03898) rose over 11% again. The imbalance between supply and demand in power semiconductors has led to the company's power semiconductor business entering the production stage.
China Electric (03898) surged more than 11% again, with a gain of 10.96% as of the time of writing, reaching 42.12 Hong Kong dollars, with a turnover of 316 million Hong Kong dollars.
Zhuzhou CRRC Times Electric (03898) rose by over 11%, reaching an increase of 10.96% at 42.12 Hong Kong dollars, with a trading volume of 316 million Hong Kong dollars.
On the news front, the imbalance between supply and demand of power semiconductors has intensified. Some IDM giants have extended delivery times for certain power semiconductor products to as long as 30 weeks. Mainstream categories such as MOSFET and IGBT are experiencing varying degrees of supply shortage. Zhuzhou CRRC Times Electric's power semiconductor business has entered the production phase. It is reported that the Yixing Phase III project has started production, and the Zhuzhou Phase III silicon carbide project is also partially in production by 2026, rapidly increasing power semiconductor capacity.
Ping An Securities pointed out that as a leading traction converter system supplier in China's rail transit industry, the company's existing traction converter system products cover various types of locomotives, EMUs, and urban rail vehicles, breaking international monopoly, achieving domestic substitution of core train systems, and leading the domestic market. In addition, the company's Beijing Emerging Eastern Aviation Equipment business has made breakthroughs, entering the industry's forefront and creating new growth opportunities. Continued optimism towards the company's "device + system + whole machine" industry chain structure and future development.
Related Articles

China Galaxy Securities: The actual production capacity of phosphorization is more than 50% greater than demand, with stronger upstream elasticity in the optical device industry chain.

New Stock Analysis | Volume Sold Lost, Cost Rate Out of Control: The Dilemma of "Pseudo Ecology" in CreatAge 3D

Morgan Stanley: Jiangsu Hengrui Pharmaceuticals (01276) signs a $15.2 billion strategic cooperation agreement with BMS to accelerate globalization process.
China Galaxy Securities: The actual production capacity of phosphorization is more than 50% greater than demand, with stronger upstream elasticity in the optical device industry chain.

New Stock Analysis | Volume Sold Lost, Cost Rate Out of Control: The Dilemma of "Pseudo Ecology" in CreatAge 3D

Morgan Stanley: Jiangsu Hengrui Pharmaceuticals (01276) signs a $15.2 billion strategic cooperation agreement with BMS to accelerate globalization process.

RECOMMEND

Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026

HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026

The Chip Stock Frenzy Is Still Accelerating
11/05/2026


